Pharma Cost Cutting Survey
Survey began 22 February 2005. Survey ended 23 March 2005.
The pharmaceutical insudtry faces many challenges ahead including blockbusters going off patent, generic competition, collapsing sales due to product withdrawal, price pressures, etc. All this puts pressure on pharma profitability and Wall Street is clamoring for cost cutting measures.
Now may be the time to end the pharmaceutical sales and marketing “arms race” and/or increase sales and marketing ROI. Pfizer has be the first to warn of deep cuts in personnel.
We would like your input on various cost-cutting and ROI strategies available to the pharmaceutical industry, how likely any of these will be adopted in the near future, and what the effect may be upon pharmaceutical marketers.
- Interactive Summary of Results (de-identified, excludes open-ended responses and comments that may identify the respondent). Allows you to use filters to examine results from different subsets of respondents (e.g., pharma company employees vs. non-pharma people, etc.)
- Pharma Marketing News Summary, which presents more detailed results. (REPRINT available).